SUSMED,Inc. (TYO:4263)
Japan · Delayed Price · Currency is JPY 1,028.00
+7.00 (0.69%)
At close: Mar 6, 2026
SUSMED,Inc. Revenue
SUSMED,Inc. had revenue of 46.00M JPY in the quarter ending December 31, 2025, with 12.20% growth. This brings the company's revenue in the last twelve months to 480.00M, up 220.00% year-over-year. In the fiscal year ending June 30, 2025, SUSMED,Inc. had annual revenue of 462.00M with 35.09% growth.
Revenue (ttm)
480.00M
Revenue Growth
+220.00%
P/S Ratio
36.01
Revenue / Employee
11.16M
Employees
43
Market Cap
17.28B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 462.00M | 120.00M | 35.09% |
| Jun 30, 2024 | 342.00M | -188.00M | -35.47% |
| Jun 30, 2023 | 530.00M | 214.00M | 67.72% |
| Jun 30, 2022 | 316.00M | 201.00M | 174.78% |
| Jun 30, 2021 | 115.00M | 81.00M | 238.24% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| MTI Ltd. | 30.41B |
| J Frontier | 21.34B |
| CE Holdings | 17.09B |
| Wellness Communications | 14.61B |
| Kusurinomadoguchi | 11.71B |
| GENOVA | 10.32B |
| Value HR | 10.07B |
| Softmax | 6.93B |